Rhizoma Coptidis for Alzheimer’s Disease and Vascular Dementia: A Literature Review

医学 血管性痴呆 痴呆 疾病 阿尔茨海默病 内科学
作者
Zhiyong Wang,Yang Yang,Meixia Liu,Yun Wei,Jiangang Liu,Hui Pei,Hao Li
出处
期刊:Current Vascular Pharmacology [Bentham Science Publishers]
卷期号:18 (4): 358-368 被引量:35
标识
DOI:10.2174/1570161117666190710151545
摘要

Alzheimer's disease (AD) and vascular dementia (VaD) are major types of dementia, both of which cause heavy economic burdens for families and society. However, no currently available medicines can control dementia progression. Rhizoma coptidis, a Chinese herbal medicine, has been used for >2000 years and is now gaining attention as a potential treatment for AD and VaD.We reviewed the mechanisms of the active ingredients of Rhizoma coptidis and Rhizoma coptidis-containing Chinese herbal compounds in the treatment of AD and VaD. We focused on studies on ameliorating the risk factors and the pathological changes of these diseases.The Rhizoma coptidis active ingredients include berberine, palmatine, coptisine, epiberberine, jatrorrhizine and protopine. The most widely studied ingredient is berberine, which has extensive therapeutic effects on the risk factors and pathogenesis of dementia. It can control blood glucose and lipid levels, regulate blood pressure, ameliorate atherosclerosis, inhibit cholinesterase activity, Aβ generation, and tau hyperphosphorylation, decrease neuroinflammation and oxidative stress and alleviate cognitive impairment. Other ingredients (such as jatrorrhizine, coptisine, epiberberine and palmatine) also regulate blood lipids and blood pressure; however, there are relatively few studies on them. Rhizoma coptidis-containing Chinese herbal compounds like Huanglian-Jie-Du-Tang, Huanglian Wendan Decoction, Banxia Xiexin Decoction and Huannao Yicong Formula have anti-inflammatory and antioxidant stress activities, regulate insulin signaling, inhibit γ-secretase activity, neuronal apoptosis, tau hyperphosphorylation, and Aβ deposition, and promote neural stem cell differentiation, thereby improving cognitive function.The "One-Molecule, One-Target" paradigm has suffered heavy setbacks, but a "multitarget- directed ligands" strategy may be viable. Rhizoma coptidis active ingredients and Rhizoma coptidiscontaining Chinese herbal compounds have multi-aspect therapeutic effects on AD and VaD.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
伶俐的无颜完成签到 ,获得积分10
1秒前
嗒嗒嗒薇完成签到 ,获得积分10
1秒前
ruochenzu发布了新的文献求助10
4秒前
现代的卿完成签到 ,获得积分10
7秒前
秉文完成签到,获得积分10
8秒前
清颜完成签到 ,获得积分10
8秒前
9秒前
科研通AI5应助安详怜蕾采纳,获得10
9秒前
atonnng完成签到,获得积分10
10秒前
RRRZZ完成签到 ,获得积分10
10秒前
10秒前
10秒前
香蕉觅云应助濮阳幼萱采纳,获得10
10秒前
老实尔烟发布了新的文献求助10
11秒前
13秒前
Leslie发布了新的文献求助10
13秒前
冷傲的道罡完成签到,获得积分10
14秒前
糖糖唐发布了新的文献求助10
16秒前
wind2631完成签到,获得积分10
16秒前
16秒前
CBP发布了新的文献求助10
17秒前
MewZero发布了新的文献求助10
20秒前
20秒前
愉快彩虹完成签到,获得积分10
22秒前
深情安青应助MurrayQ采纳,获得30
23秒前
tree完成签到,获得积分10
24秒前
luchener发布了新的文献求助10
25秒前
28秒前
28秒前
31秒前
qingtian414完成签到,获得积分10
31秒前
xiaona发布了新的文献求助10
32秒前
32秒前
ReiceChen发布了新的文献求助10
32秒前
Ethanyoyo0917完成签到,获得积分10
33秒前
34秒前
ding应助Psr采纳,获得10
36秒前
37秒前
37秒前
高分求助中
Разработка метода ускоренного контроля качества электрохромных устройств 500
Chinesen in Europa – Europäer in China: Journalisten, Spione, Studenten 500
Arthur Ewert: A Life for the Comintern 500
China's Relations With Japan 1945-83: The Role of Liao Chengzhi // Kurt Werner Radtke 500
Two Years in Peking 1965-1966: Book 1: Living and Teaching in Mao's China // Reginald Hunt 500
Epigenetic Drug Discovery 500
Hardness Tests and Hardness Number Conversions 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3816980
求助须知:如何正确求助?哪些是违规求助? 3360427
关于积分的说明 10407756
捐赠科研通 3078348
什么是DOI,文献DOI怎么找? 1690731
邀请新用户注册赠送积分活动 814032
科研通“疑难数据库(出版商)”最低求助积分说明 767985